Fig. 4.
Long-term follow-up of the dynamics of alanine aminotransferase (HCV) antibody optical density (OD) and recombinant immunoblot assay (RIBA) profiles in one patient with sustained virological response (SVR) and one patient with persistently normal alanine aminotransferase (ALT) and detectable HCV-RNA. aBaseline. bEnd of treatment. (A) Patients with SVR (resolved infection). (B) Patient with persistently normal ALT and detectable serum HCV-RNA (ongoing infection).